ICH GCP E6 R (3) COMPLIMENTARY Webinar Series
COMPLIMENTARY: Webinar Series (8 Sessions)
Webinar Series Description
Each month, Liz covers critical topics related to ICH GCP E6 (R3). These webinars are designed to provide the insights and context for the changes, an overview of the changes and impact to your clinical trials, recommended next steps, and Q & A.
These are not ‘boring’, ‘talking head’ virtual trainings!
Liz is an expert biotech and pharma trainer, a certified instructional designer and master trainer. As a master virtual trainer, Liz develops and delivers expert content that is thought provoking, engaging, interactive and solution focused trainings.
Liz uses advanced technology tools and whiteboards for a training ‘experience’ that mirrors in-person trainings!
Registration is REQUIRED Here: https://woolcg.zoom.us/meeting/register/tZEkf-GuqjwpGtysBmXln9HgQxLo0DLoEbTY
SCHEDULE
Overview of Changes - and the HOT Topics for Compliance!
Date: July 11, 2024
Presenter: Liz Wool CCRA, FACRP
Time: 12 pm – 2 pm ET
Agenda
1. Introduction and Context for Changes
2. Where do I find all of the ‘requirements’ in this new Guideline? Hint- NOT all are in ONE place!
3. Overview of ICH GCP E6 (R3) Changes
4. HOT Topics for Compliance
5. Implications for Clinical Trials
6. Don't forget ICH E8 R(1)
7. Next Steps
8. Q&A Session
Vendor (Service Provider) Requirements Changes
Date: August 8, 2024
Presenter: Liz Wool CCRA, FACRP
Time: 12 pm – 2 pm ET
Agenda:
1. Introduction and Context for Changes
2. Overview of Changes for Vendor (Service Provider) & Oversight
3. Implications for Clinical Trials
4. Next Steps
5. Q&A Session
Sponsor Changes & **NEW** Sponsor Oversight
Date: September 19, 2024
Presenter: Liz Wool CCRA, FACRP
Time: 12 pm – 2 pm ET
Agenda
1. Introduction and Context for Changes
2. Overview of Changes to Sponsor Responsibilities
3. **NEW Section** Sponsor Oversight
4. Implications for Clinical Trials
5. Next Steps
6. Q&A Session
Risk Based Quality Management/Clinical Trial Risk Management (Quality Management) Changes
Date: October 10, 2024
Presenter: Liz Wool CCRA, FACRP
Time: 12 pm – 2 pm ET
Agenda
1. Introduction and Context for Changes
2. Overview of Changes to Risk Management
3. QTL requirements
4. Implications for Clinical Trials
5. Next Steps
6. Q&A Session
Investigator-Site Responsibilities Changes
Date: November 21, 2024
Presenter: Liz Wool CCRA, FACRP
Time: 12 pm – 2 pm ET
Agenda
1. Introduction and Context for Changes
2. Overview of Changes to Investigator-Site Responsibilities
3. Implications for Clinical Trials
4. Next Steps
5. Q&A Session
**NEW Data Governance &**NEW Detailed Computerized Systems Changes
Date: December 12 ,2024
Presenter: Liz Wool CCRA, FACRP
Time: 12 pm – 2 pm ET
Agenda
1. Introduction and Context for Changes
2. Overview of Computerized Systems Requirements
3. Overview of Data Governance Requirements
4. Implications for Clinical Trials
5. Next Steps
6. Q&A Session
Trial Master File/Essential Documents
Date: January 9, 2025
Presenter: Liz Wool CCRA, FACRP
Time: 12 pm – 2 pm ET
Agenda
1. Introduction and Context for Changes
2. Overview of Changes Essential Documents & Implications for the Trial Master File (TMF)
1. Implications for Clinical Trials
2. Next Steps
3. Q&A Session
IRB/IEC Changes
Date: February 9, 2025
Presenter: Liz Wool CCRA, FACRP
Time: 12 pm – 2 pm ET
Agenda
3. Introduction and Context for Changes
4. Overview of Changes for the IRB/IEC
4. Implications for Clinical Trials
5. Next Steps
6. Q&A Session